Catheter system and method for boring through blocked vascular passages

Information

  • Patent Grant
  • 10869685
  • Patent Number
    10,869,685
  • Date Filed
    Thursday, March 15, 2018
    6 years ago
  • Date Issued
    Tuesday, December 22, 2020
    3 years ago
Abstract
A rotating cutting head catheter for passage through chronic total occlusions or other refractory atherosclerotic plaque from diseased arteries is disclosed. The catheter's rotating cutting head is designed to reside safely within an outer protective sheath when not in use. The outer protective sheath contains one or more helical grooves or slots, and the cutting head contains protruding blades or projections that fit into these helical grooves or slots. Application of torque to an inner catheter or wire attached to the cutting head applies spin to the cutting head, and the force of the sheath's helical grooves or slots against the cutting head's protruding blades or projections advances the cutting head outward from the protective sheath. Once extended, the cutting head may now rotate freely. The device may use a guidewire to direct the cutting head to the desired position.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


BACKGROUND

A number of vascular diseases, such as coronary artery disease and peripheral vascular disease, are caused by the build-up of fatty atherosclerotic deposits (plaque) in the arteries. These deposits limit blood flow to the tissues that are supplied by that particular artery. Risk factors for this type of disease include advanced age, diabetes, high blood pressure, obesity, history of smoking, and high cholesterol or triglycerides.


When these deposits build up in the arteries of the heart, the problem is called coronary artery disease (CAD). When these deposits build up in the arteries of a limb, such as a leg, the condition is called peripheral artery disease (PAD). Symptoms of CAD - angina, heart disease, and heart attacks, are well known. Symptoms of PAD can include pain on walking, and wounds that do not heal. If PAD is not treated, it can eventually produce critical limb ischemia (CLI), gangrene, and loss of limb. Roughly 30% of the population over the age of 70 suffers from PAD.


When the plaque builds up to the point where an artery is totally occluded, the obstruction is referred to as a Chronic Total Occlusion (CTO). CTOs can confound the treatment of CAD, because the sudden loss of heart muscle can lead to sudden death. A CTO that occludes the peripheral arteries for PAD patients is also extremely serious. PAD patients that suffer from a CTO often enter a downward spiral towards death. Often the CTO in a peripheral artery results in limb gangrene, which requires limb amputation to resolve. The limb amputation in turn causes other complications, and roughly half of all PAD patients die within two years of a limb amputation.


For both CAD and advanced PAD, prompt treatment of such blockages is thus essential. Here, less invasive angioplasty or atherectomy procedures have many advantages. In these procedures, a catheter is inserted into the diseased artery and threaded to the blocked region. There the blockage may be either squeezed into a hopefully more open position by pressure from an inflated catheter balloon (balloon angioplasty), the blocked region may be kept open by a stent, or alternatively a physician may use a catheter to surgically remove the plaque from the inside of the artery (atherectomy).


As an example, for the treatment of PAD, atherectomy devices such as the Fox Hollow (now ev3) SilverHawk™ catheter (U.S. Pat. No. 6,027,514), are often used. These catheters may be threaded (usually with the aid of a guidewire) up the artery to a blocked region. There, the physician will usually position the catheter to make multiple passes through the blocked region of the artery, each time shaving a way a ribbon of plaque. The shaved ribbons of plaque are stored in the hollow nose of the device. By making multiple passes, the plaque may be substantially reduced, blood circulation may be restored to the limb, and the limb in turn saved from amputation.


In order to effectively treat the plaque, however, most modern catheters need to be threaded past the blocked region of the artery. This is because the active portions of most catheters, which are used to treat the blockage, are usually located on the side of the catheter, rather than on the tip of the catheter. This is due to simple mechanical necessity. The tip of the catheter must have a very small surface area, and thus is able to treat only a very small portion of the diseased artery. By contrast, the side of the catheter has a much larger surface area, and the catheter side thus conforms nicely to the sides of the diseased artery. Thus stents, balloons, atherectomy cutting tools, etc., are usually mounted on the sides of the catheter. The catheter must be threaded past the blocked portion of the artery in order to function properly.


When the artery is only partially blocked by plaque, the catheter can usually be maneuvered past the obstruction, and the active portions of the catheter can thus be brought into contact with the diseased portion of the artery. However when the artery is totally blocked, as is the case with a CTO, this option is no longer possible. The tip of the catheter encounters the obstruction, and further forward motion is blocked.


Simply trying to force a typical catheter past the obstruction usually isn't possible. The obstructions are typically composed of relatively tough fibrous material, which often also includes hard calcium deposits as well. Often, when physicians attempt to force guidewires or catheters past such obstructions, the guidewire or catheter device may instead exit the artery and enter the lumen outside the artery. This further damages the artery, further complicates the procedure, and decreases the chance of success. As previously discussed, the consequences of such procedure failures have a high mortality rate. Thus improved methods to allow catheters and guidewires to more readily penetrate through hardened plaque and CTO are thus of high medical importance.


A good summary of the present state of the art may be found in an article by Aziz and Ramsdale, “Chronic total occlusions—a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel?” Heart 2005; 91; 42-48.


Previous attempts to produce devices for cutting through hardened plaque include U.S. Pat. No. 5,556,405 to Lary, No. 6,152,938 to Curry, and No. 6,730,063 to Delaney et al.


U.S. Pat. No. 5,556,405 teaches an incisor catheter which features a bladed head stored in a catheter housing, which contains a number of slits though which the blades protrude. The blade is activated by a push-pull catheter. When the push-pull catheter is pushed, the bladed head protrudes through the slits in the housing, and the blade thus comes into contact with hardened plaque material. The blade does not rotate, but rather delivers linear cuts.


U.S. Pat. No. 6,152,938 teaches a general purpose catheter drilling device for opening a wide variety of different blocked (occluded) tubes. The device anchors the tip of the drill head against a face of the occlusion, and partially rotates the drill head using a rein attached to the drill head so that the drill head faces at an angle.


U.S. Pat. No. 6,730,063 teaches a catheter device for chemically treating calcified vascular occlusions. The device is a fluid delivery catheter that delivers acidic solutions and other fluids to calcified plaque with the objective of chemically dissolving the calcified material.


Several catheter devices for traversing CTO obstructions are presently marketed by Cordis Corporation, FlowCardia Technology, Kensey Nash Corporation, and other companies. Cordis Corporation, a Johnson and Johnson Company, produces the Frontrunner® XP CTO catheter (formerly produced by LuMend Corporation). This catheter, discussed in U.S. Pat. No. 6,800,085 and other patents, has a front “jaw” that opens and closes as it traverses the catheter. The jaw itself does not cut, but rather attempts to pry open the CTO as the catheter passes.


Other catheter devices use various forms of directed energy to traverse CTOs. For example, FlowCardia Technology, Sunnyvale, Calif., produces the Crosser system, taught in U.S. Pat. No. 7,297,131 and other patents. This system uses an ultrasonic transducer to deliver energy to a non-cutting catheter head. This catheter head itself has a relatively small diameter and does not have any blades. Rather, the head, through rapid (ultrasonic) vibration is able to push its way through a variety of different occlusions.


Kensey Nash Corporation, Exton, Pa. (formerly Intraluminal Therapeutics, Inc.), produces the Safe-Cross CTO system. This system, taught in U.S. Pat. Nos. 6,852,109 and 7,288,087, uses radiofrequency (RF) energy. The catheter itself is also directed in its movement by an optical (near-infrared light) sensor which can sense when the tip of the catheter is near the wall of the artery. The optical sensor tells the operator how to steer the catheter, and the RF ablation unit helps the operator ablate material and cross occluded regions.


Although ingenious, the success rates with these devices still leave much to be desired. According to Aziz, the best reported success rates of overcoming CTOs with prior art devices range from 56% to 75%. Aziz further teaches that the average success rates are only in the 50-60% range. Given the huge negative impact that unsuccessfully cleared CTOs have on patient morbidity and mortality, clearly further improvement is desirable. An additional problem with these prior art CTO clearing devices is that simply cutting a small channel though the CTO may not be sufficient to totally resolve the medical problem. Occasionally, the device that traverses the CTO should also remove (debulk) a substantial portion of the occlusion. This is because as previously discussed, removal of a substantial portion of the occlusion may be required in order to allow catheters with side mounted stents, balloons, and atherectomy cutting tools to get access to the damaged portions of the artery and make more lasting repairs. Thus improved CTO “unclogging” devices that can do the more substantial amount of CTO debulking required to allow other types of catheters to pass are also desirable.


Thus there remains a need for devices that can effectively traverse CTOs and remove more substantial amounts of hardened or calcified plaque. Such devices would enable stents and other devices, such as SilverHawk atherectomy catheters, balloon catheters, etc. to be more successfully used in high occlusion situations. This in turn should lead to improved patient outcomes and a reduction in patient morbidity and mortality.


SUMMARY OF THE DISCLOSURE

The present invention teaches a novel rotating cutting head catheter for creating a passage through refractory material, such as chronic total occlusions, refractory atherosclerotic plaque, gallstones, kidney stones, etc. from diseased arteries, veins, or other body lumens. The catheter's rotating cutting head is designed to reside safely within an outer protective sheath head when not in use, and this sheath head is mounted on the distal end of the catheter.


The outer protective sheath head contains one or more helical grooves or slots, and the cutting head contains protruding blades or projections that fit into these helical grooves or slots. Application of torque to an inner torque communicating connector (a catheter or wire or coil, or any torque communicating mechanism attached to the cutting head) applies spin to the cutting head, and the force of the sheath head's helical grooves against the cutting head's protruding blades or projections advances the cutting head outward from the protective sheath. Once extended, the cutting head may now rotate freely. In some embodiments, the center of the catheter and even the cutting head itself may be hollow, and the device may use a guidewire to direct the catheter and the cutting head to the desired position. Alternatively the guidewire may be attached to a guide that is attached to the outside of the catheter tube. In at least some embodiments, this sheath head acts as motion stop, and may contain one or more motion stop elements (such as a mechanical barrier) designed to restrict the forward extension of the cutting head.


Depending upon the angle and nature of the cutting head's protruding blades, the blades may either be designed to simply cut thorough the occluding material, without actually dislodging the occluding material from the body lumen, or alternatively the blades may be designed to both cut through the occluding material, and sever its link to the body lumen, thereby dislodging the occluding material from the body lumen. In this case, the cutting head can act to actually remove (debulk) a substantial portion of the occlusion.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows an overview of the catheter device including the handle, the catheter, and the catheter head.



FIG. 2 shows the exterior of the catheter head with the cutting head extended out from the sheath head.



FIG. 3 shows a drawing of the catheter head (mounted on a guidewire) with the cutting head extended and cutting into a CTO plaque in an occluded artery.



FIG. 4 shows a diagram of the cutting head unscrewing from protective shroud of the catheter head's sheath head.



FIG. 5 shows a close up of the catheter head showing the cutting head screwed into a stored position inside the catheter head's protective sheath head.



FIG. 6 shows a close up of a cutting head with an alternate protruding blade design.





DETAILED DESCRIPTION

Although, throughout this discussion, applications of this device for creating a passage through refractory atherosclerotic plaque from arteries, particularly coronary or peripheral limb arteries, are frequently used as examples, it should be understood that these particular examples are not intended to be limiting. Other applications for the present technology may include removal of kidney stones, in which case the device will be intended to traverse the ureters; gallstones, in which case the device will be intended to traverse the bile duct; enlarged prostate blockage of the urethra, in which case the device will be intended to traverse the urethra; blocked fallopian tubes, in which case the device will be intended to traverse the fallopian tubes; treatment of blood clots, removal of material trapped in the lungs, etc. In general, any unwanted material occupying space in a body lumen may be surgically removed by these techniques. Similarly, although use in human patients is cited in most examples, it should be evident that the same techniques may be useful in animals as well.


Helical drill bits and self-tapping screw bits are widely known to be highly effective at penetrating through materials as soft as wax and as refractory as rock and metal, and indeed such devices are widely used for such purposes. Although effective, drill bits are typically considered to be both powerful and extremely crude. As anyone who has ever attempted to use an electric drill can attest, drill devices, although admittedly effective at removing material, would seem to be totally unsuited for delicate vascular surgery, particularly at sites hidden deep within the body. Helical self-tapping screw bits are designed slightly differently. Although just as effective at cutting through various materials, drill bits are configured to both cut and then remove the material, while self-tapping screw bits are designed primarily for cutting a passage through the material. For either type of device, the problem is not the efficacy of cutting or occlusion removal; the problem is one of preventing inadvertent damage to the surrounding artery.


Surprisingly however, the present invention teaches that if the prejudice against such crude and powerful methods is overcome, and suitable protection and control devices are devised to control the crude and apparently overwhelming power of such “drill bit” devices, catheter “drill bit” devices suitable for delicate vascular surgery, which are both powerful at cutting or removing occlusions, yet specific enough to avoid unwanted damage to artery walls, may be produced.


Thus, in a first aspect of the present invention, the superior material cutting/removing properties of a “drill bit” like material removal device (or self-threading helical screw bit) are combined with suitable protection and catheter guidance mechanisms which allow such powerful cutting devices to be safely and effectively used within the confines of delicate arteries and other body lumens.


To do this, precise control must be exerted over the cutting edge of the “drill bit”. The bit or “cutting head” should normally be sheathed or shielded from contact with artery walls, so that inadvertent damage to artery walls can be avoided while the head of the catheter is being threaded to the artery to the occluded region. Once at the occlusion, the cutting portion of the cutting head (bit) should be selectively exposed only to the minimal extent needed to perform the relevant occlusion cutting activity. The rotation direction of the cutting head may optionally be varied, for example by rotating the head counter-clockwise to produce a blunt dissection through the obstacle or occlusion, and then clockwise while pulling back on the entire assembly. Once the desired cuts are made, the cutting head should then be quickly returned to its protective sheath. The entire device should operate within the millimeter diameters of a typical artery, and should be capable of being threaded on a catheter for a considerable distance into the body.


Suitable techniques to achieve these objectives are taught in the following figures and examples.



FIG. 1 shows an overview of the catheter device (100) including the catheter body (102), the catheter handle (104), and the catheter head (106). The catheter body and catheter head, and often even the cutting head, are often hollow and are capable of accommodating a guidewire (not shown). A magnified view of the catheter head, showing the rotating cutting head in an extended configuration (108), extended outside of the sheath portion of the catheter head (here this sheath is called the “sheath head”) (106) is also shown.



FIG. 2 shows the exterior of the sheath head portion of the catheter head (106) with the cutting head (108) extended. This cutting head will normally have one or more projecting side blades or with cutting edges (202), and additionally will often have cutting edges on the front (204) as well. The center of sheath head portion of the catheter head (106) and catheter (102) may be hollow to accommodate a guidewire. In some embodiments, the guidewire will exit the sheath portion of the catheter head (106) on the side of catheter head (106) prior to cutting head (108) by a side opening (not shown). In other embodiments, cutting head (108) will itself be hollow and the guidewire will exit the end of cutting head (108) through opening (206).


In the closed configuration, the rotating cutting head (108) is retracted inside the sheath head portion of catheter head (106) and the cutting edges or projections (202) from the cutting head (108) fit into helical slots or grooves (208). This sheathed configuration prevents projecting side cutting edges (202) and front cutting edges (204) from accidentally contacting the walls of the artery.



FIG. 3 shows a drawing of the catheter head (106) (with the cutting head extended from the sheath head) cutting into a CTO (304) in an occluded artery (306). In this example, the catheter and catheter head are mounted on and guided by a guidewire (302), however this will not always be the case.


As should be clear, the cutting edge of the “drill bit/screw-thread” like cutting head can easily damage artery lining (306). In order to avoid such accidental damage, precise control over the extent of cutting head exposure is needed. Methods to achieve such precise control are shown in FIG. 4.



FIG. 4 shows some of the details of how the cutting head (108) is unscrewed from the helical slots or grooves (208) of the sheath head portion of catheter head (106), thus exposing cutting edges (202) and (204). In (402), the cutting head (108) is shown fully exposed. The cutting head has become fully unscrewed from helical slots (208) and is fully extended. An optional projecting post or guide (404) mounted on cutting head (108) may act to guide the rotating cutting head into and out of the helical screw-like slots (208). The coupling (406) that couples cutting head (108) with a torque transmitting (torque communicating connector) inner catheter tube or cable (408) is in the extreme distal position inside of the sheath head portion of catheter head (106).


In (410), the cutting head is shown in its fully retracted position. Normally the cutting head will be stored in this fully retracted position so that it can be introduced into the artery via a guidewire, and be directed to the occlusion or plaque region, without damaging non-target regions of the artery. Note that the coupling (406) is in the fully distal position in the sheath head portion of catheter head (106), and that the protruding cutting blades (202) of cutting head (108) are fully screwed into helical screw slots (208).


In some situations, a guidewire [FIG. 3 (302)] leading to the obstruction will already have been introduced. In fact, a previous attempt to perform atherectomy may have already been made, and this attempt may have been frustrated by refractory plaque, such as a plaque covered with hard calcium deposits, whereupon the physician may make a decision to use the present cutting device to punch through this refractory plaque.


In use, the catheter head (106) and catheter tube (102) are attached to the guidewire and are then introduced into the artery via an appropriate incision. The catheter handle (104) will remain outside of the body. The location of the obstruction will generally be known, and in fact the obstruction may be imaged by fluoroscopy or other technique. Catheter head (106) is brought up against the obstruction, and the operator will then apply torque, often via a device mounted on catheter handle (104). This torque is usually transmitted to the catheter head (106) via an inner torque conducting catheter or wire (408), here termed a “torque communicating connector”. Usually outer catheter (102) will not conduct torque. Outer catheter (102) remains approximately stationary (i.e. does not rotate) and similarly the sheath head portion of catheter head (106) and the helical screw slots or grooves (208) also do not rotate.


The torque is communicated via coupling (406) to cutting head (108). This torque essentially causes cutting head (108) to “unscrew” from its retracted position in the sheath head portion of catheter head (106) via the action of the protruding blade edges (202) against helical slots or grooves (208). This “unscrewing” circular motion is shown by the curved arrow (412). As cutting head (108) unscrews, it starts to advance and protrude outside of the protective sheath head shroud.


In (420), the cutting head (108) is now shown in a partially unscrewed or partially extended position. Note that the protruding blade edges (202) have moved relative to the helical sheath head screw slots or grooves (208). Thus the blade edges (202) are now partially unscrewed from the helical screw slots (208) and are partially exposed. Cutting head (108) now is protruding out from the sheath head portion of catheter head casing or shroud (106), and the coupling (406) has moved partially toward the distal end of the catheter.


It should be evident that by reversing the direction of the torque, the cutting head may be again retracted into the sheath head when this is desired. The catheter can be repositioned for another cut, and the process of cutting head extension, cutting, and retraction can be repeated as many times as necessary.


Thus the present invention controls the aggressive cutting power of the “drill bit” cutting head by exposing only as much of the cutting head at a time as needed for the task at hand.



FIG. 5 shows a close up of the sheath head portion of the catheter head showing the cutting head screwed into a stored position inside the protective sheath head shroud. This angle allows the helical screw slots or grooves (208) to be easily seen, and cutting head (108) can also be seen inside of the sheath head portion of catheter head (106).



FIG. 6 shows a close up of an alternate design cutting head (108) with spiral shaped protruding cutting edges (202).


The sheath head portion of catheter head (106) will normally be between about 1 to 2.2 millimeters in diameter, and the catheter body (102) will typically also have a diameter of approximately 1 to 3 millimeters (3-9 French), and a length between 50 and 200 cm. The sheath head may be made from various materials such as hard plastics, metals, or composite materials. Examples of such materials include NiTi steel, platinum/iridium or stainless steel.


Although sheath head (106) contains slots or grooves designed to impart forward motion to cutting head (108) when cutting head is rotated, and although these slots or grooves are referred to as “helical” grooves or slots, due to the short length of the sheath head and overall catheter head, the slots or grooves do not have to be in the exact mathematical shape of a helix. In fact a variety of shapes that differ somewhat from a mathematically pure helix configuration will suffice. In general, the slot or groove must be such that torque applied to the cutting head causes the cutting head to both rotate and advance, and any such slot or groove is here designated as a “helical” slot or groove. Also, for this discussion, a “slot” is considered to be an opening that extends from the inside to the outside of the hollow catheter head (106), while a “groove” is similar to a rifle groove in that a “groove” does not extend all the way from the inside of the hollow sheath head to the outside, but rather only penetrates partway through the sheath head material.


The cutting head (108) will often be made of materials such as steel, carbide, or ceramic. The blades of the cutting head (202), (204) can optionally be hardened by coating with tungsten carbide, ME-92, etc. Materials suitable for this purpose are taught in U.S. Pat. Nos. 4,771,774; 5,312,425; and 5,674,232. The angle of the blades and the details of their design will differ depending upon if the head is intended to simply cut through the occluding material, of if it is intended to cut through and actually remove (debulk) portions of the occlusion. For example, blades intended for to remove material may curve at an angle such that they will tend to sever the link between the occluding material and the body lumen, while blades intended just for cutting will have an alternate angle that tends not to sever this link.


In some embodiments, the catheter may be composed of two different tubes. In this configuration, there may be an outer catheter tube (102), which will often be composed of a flexible biocompatible material. There may also be an inner tube (408) chosen for its ability to transmit torque from the catheter handle (104) to the cutting head (108) (via coupling (406)). The inner torque transmitting tube (which is one possible type of “torque communicating connector”) is able to twist relative to the outer catheter tube so that when torque is applied to the inner tube at the handle end (104), the cutting head (108) will rotate, but the catheter sheath head itself, which is connected to the outer catheter tube, will remain roughly stationary. Alternatively a cable may be used in place of inner tube (408).


The outer catheter body (102) may often be made from organic polymer materials extruded for this purpose, such as polyester, polytetrafluoroethylene (PTFE), polyurethane, polyvinylchloride, silicon rubber, and the like. The inner torque conducting catheter (408) may be composed of these materials or alternatively may be composed from metal coils, wires, or filaments.


In many embodiments, the catheter will be designed to be compatible with a monorail guidewire that has a diameter of about 0.014″, or between 0.010″ and 0.032″. For example, the outer catheter jacket may contain attached external guides for the monorail guidewire. In this case, the guidewire may exit these external guides either prior to the catheter head, or midway through the catheter head. Alternatively, the catheter may be hollow, and be located over the guidewire for the entire length of the catheter.


The catheter handle (104) will normally attach to both outer catheter tube (102), and inner tube or cable (408). Usually handle (104) will contain at least a knob, dial, or lever that allows the operator to apply torque to the inner torque transmitting tube or cable (408). In some embodiments, sensors may be used to determine how much the cutting head (108) has rotated or extended relative to the sheath head portion of catheter head (106), and these sensors, possibly aided by a mechanical or electronic computation and display mechanism, may show the operator how much the cutting head has rotated and or extended.


In some embodiments, the catheter handle (104) will be designed with knobs or levers coupled to mechanical mechanisms (such as gears, torque communicating bands, etc.) that manually rotate and advance/retract the catheter tip, and the operator will manually control the tip with gentle slow rotation or movement of these knobs or levers. In other embodiments the catheter handle will contain a mechanism, such as an electronic motor, and a control means, such as a button or trigger, that will allow the user to rotate and advance the cutting head in a precise and controlled manner. This mechanism may, for example, consist of a microprocessor or feedback controlled motor, microprocessor, and software that may act to receive information from a cutting head rotation or extension sensor, and use this rotation feedback data, in conjunction with operator instructions delivered by the button or trigger, to advance or retract the cutting head by a precise amount for each operator command. This way the operator need not worry about any errors induced by the spring action of the inner torque transmitting tube or cable (408). The microprocessor (or other circuit) controlled motor can automatically compensate for these errors, translate button or trigger presses into the correct amount of torque, and implement the command without requiring further operator effort. Alternatively non-microprocessor methods, such as a vernier or a series of guided markings, etc., may be used to allow the operator to compensate for differences in the rotation of the torque communicating connector and the rotation of the cutting head, or for the extent that which said cutting head exits said hollow sheath head.


In some embodiments, the catheter head may be equipped with additional sensors, such as ultrasonic sensors to detect calcified material, optical (near infrared) sensors to detect occlusions or artery walls, or other medically relevant sensors. If these sensors are employed, in some cases it may be convenient to locate the driving mechanisms for these sensors in the catheter handle (104) as well.


Additional means to improve the efficacy of the cutting head may also be employed. Thus the cutting head may be configured to vibrate at high (ultrasonic) frequency, perform radiofrequency (RF) tissue ablation, generate localized areas of intense heat, conduct cutting light (e.g. laser or excimer laser), or other directed energy means.


The cutting head may be composed of alternative designs and materials, and these designs and materials may be selected to pick the particular problem at hand. As an example, a cutting head appropriate for use against a calcified obstruction may differ from the cutting head appropriate for use against a non-calcified obstruction. Similarly the cutting head appropriate for use against a highly fibrous obstruction may be less appropriate against a less fibrous and fattier obstruction. The length or size of the obstruction may also influence head design.


Although multiple catheters, each composed of a different type of cutting head, may be one way to handle this type of problem, in other cases, a kit composed of a single catheter and multiple cutting heads (108) and optionally multiple sheath heads (106) may be more cost effective. In this type of situation, the cutting heads (108) may be designed to be easily mounted and dismounted from coupling (406). A physician could view the obstruction by fluoroscopy or other technique, and chose to mount the cutting head design (and associated sheath head design) best suited for the problem at hand. Alternatively, if the blades (202), (204) on cutting head (108) have become dull or chipped from use during a procedure, a physician may chose to replace dull or chipped cutting head (108) with a fresh cutting head, while continuing to use the rest of the catheter.


For some applications, it may also be useful to supply various visualization dyes or therapeutic agents to the obstruction using the catheter. Here, the dye or therapeutic agent may be applied by either sending this dye up to the catheter head through the space between the exterior catheter (102) and the interior torque catheter (408), or alternatively if torque catheter (408) is hollow, through the interior of torque catheter (408). If cutting head (108) also has a hollow opening (206), then the dye or therapeutic agent may be applied directly to the obstruction, even while cutting head (108) is cutting through the obstruction.


Examples of useful dyes and therapeutic agents to apply include fluoroscopic, ultrasonic, MRI, fluorescent, or luminescent tracking and visualization dyes, anticoagulants (e.g. heparin, low molecular weight heparin), thrombin inhibitors, anti-platelet agents (e.g. cyclooxygenase inhibitors, ADP receptor inhibitors, phosphodiesterase inhibitors, Glycoprotein IIB/IIIA inhibitors, adenosine reuptake inhibitors), anti-thromboplastin agents, anti-clot agents such as thrombolytics (e.g. tissue plasminogen activator, urokinase, streptokinase), lipases, monoclonal antibodies, and the like.


In some embodiments, it may be useful to construct the cutting head out of a material that has a radiopaque signature (different appearance under X-rays) that differs from the material used to construct the hollow sheath head portion of the catheter head. This will allow the physician to directly visualize, by fluoroscopic or other x-ray imaging technique, exactly how far the cutting head has advanced outside of the catheter sheath head.

Claims
  • 1. A method of delivering a guidewire across an occlusion in a vascular lumen, the method comprising: passing a distal end of a catheter through the vascular lumen to the occlusion, wherein the catheter comprises an elongate catheter body and a cutting head having a blade and a protective housing, the protective housing having a slot therein;positioning the cutting head in a cutting configuration by extending the blade through the slot;rotating the cutting head relative to the protective housing in the cutting configuration to advance the cutting head across the lesion;positioning the cutting head in a stowed configuration by retracting the blade into the protective housing through the slot; andpassing a guidewire through a guidewire passageway extending through the catheter body and cutting head such that the guidewire spans the occlusion.
  • 2. The method of claim 1, wherein rotating the cutting head in the cutting configuration comprises rotating the cutting head both clockwise and counterclockwise.
  • 3. The method of claim 2, wherein rotating the cutting head in the cutting configuration in the clockwise direction provides a different mode of aggressiveness relative to rotating the cutting head in the cutting configuration in the counterclockwise direction.
  • 4. The method of claim 1, further comprising using the guidewire spanning the occlusion to treat the occlusion by atherectomy, stenting, or balloon angioplasty.
  • 5. The method of claim 1, further comprising applying torque to a torque communicating connector connected to the cutting head to extend the cutting head from the stowed configuration to the cutting configuration.
  • 6. The method of claim 1, wherein passing a distal end of a catheter through the vascular lumen to the occlusion comprises passing the distal end through the vascular lumen while the blade is in the stowed configuration.
  • 7. The method of claim 1, wherein the cutting head is in the cutting configuration only for as much as time as is needed to cut through the occlusion.
  • 8. The method of claim 1, further comprising repeating the steps of positioning the cutting head in a cutting configuration rotating the cutting head in the cutting configuration, and positioning the cutting head in a stowed configuration.
  • 9. The method of claim 1, wherein the blade is curved and the slot is curved.
  • 10. The method of claim 1, wherein the cutting head in the stowed configuration is fully retracted into and covered by the protective housing.
  • 11. The method of claim 1, wherein positioning the cutting head in a cutting configuration comprises rotating the cutter relative to the protective housing to extend the blade through the slot.
  • 12. A method of delivering a guidewire across an occlusion in a vascular lumen, the method comprising: passing a distal end of a catheter through the vascular lumen to the occlusion, wherein the catheter comprises an elongate catheter body and a cutting head having a blade and a protective housing, the protective housing having a slot therein, wherein the blade is curved and the slot is curved;positioning the cutting head in a cutting configuration by extending the blade through the slot;rotating the cutting head in the cutting configuration to advance the cutting head across the lesion;positioning the cutting head in a stowed configuration by retracting the blade into the protective housing through the slot; andpassing a guidewire through a guidewire passageway extending through the catheter body and cutting head such that the guidewire spans the occlusion.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/752,325, filed Jan. 28, 2013, entitled “CATHETER SYSTEM AND METHOD FOR BORING THROUGH BLOCKED VASCULAR PASSAGES”, which is a continuation of U.S. patent application Ser. No. 13/277,167, filed on Oct. 19, 2011, entitled “CATHETER SYSTEM AND METHOD FOR BORING THROUGH BLOCKED VASCULAR PASSAGES”, now U.S. Pat. No. 8,361,097 B2, which is a continuation of U.S. patent application Ser. No. 12/108,433, filed on Apr. 23, 2008, entitled “CATHETER SYSTEM AND METHOD FOR BORING THROUGH BLOCKED VASCULAR PASSAGES”, now U.S. Pat. No. 8,062,316 B2, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (436)
Number Name Date Kind
3367727 Ward et al. Feb 1968 A
3908637 Doroshow Sep 1975 A
4178935 Gekhaman et al. Dec 1979 A
4487206 Aagard Dec 1984 A
4527553 Upsher Jul 1985 A
4552554 Gould et al. Nov 1985 A
4611600 Cohen Sep 1986 A
4621353 Hazel et al. Nov 1986 A
4639091 Huignard et al. Jan 1987 A
4654024 Crittenden et al. Mar 1987 A
4681106 Kensey et al. Jul 1987 A
4686982 Nash Aug 1987 A
4691708 Kane Sep 1987 A
4771774 Simpson et al. Sep 1988 A
4841977 Griffith et al. Jun 1989 A
4857046 Stevens et al. Aug 1989 A
4920961 Grossi et al. May 1990 A
4926858 Gifford, III et al. May 1990 A
5000185 Yock Mar 1991 A
5018529 Tenerz et al. May 1991 A
5041082 Shiber Aug 1991 A
5047040 Simpson et al. Sep 1991 A
5085662 Willard Feb 1992 A
5099850 Matsui et al. Mar 1992 A
5178153 Einzig Jan 1993 A
5182291 Gubin et al. Jan 1993 A
5190050 Nitzsche Mar 1993 A
5192291 Pannek, Jr. Mar 1993 A
5312415 Palermo May 1994 A
5312425 Evans et al. May 1994 A
5321501 Swanson et al. Jun 1994 A
5333142 Scheps Jul 1994 A
5358472 Vance et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5372601 Lary Dec 1994 A
5383460 Jang et al. Jan 1995 A
5383467 Auer et al. Jan 1995 A
5425273 Chevalier Jun 1995 A
5429136 Milo et al. Jul 1995 A
5431673 Summers et al. Jul 1995 A
5437284 Trimble Aug 1995 A
5459570 Swanson et al. Oct 1995 A
5460168 Masubuchi et al. Oct 1995 A
5465147 Swanson Nov 1995 A
5507795 Chiang et al. Apr 1996 A
5517998 Madison May 1996 A
5556405 Lary Sep 1996 A
5607394 Andersen et al. Mar 1997 A
5620426 Braithwaite Apr 1997 A
5632754 Farley et al. May 1997 A
5632755 Nordgren et al. May 1997 A
5674232 Halliburton Oct 1997 A
5681336 Clement et al. Oct 1997 A
5690634 Muller et al. Nov 1997 A
5722403 McGee et al. Mar 1998 A
5728148 Bostrom et al. Mar 1998 A
5795295 Hellmuth et al. Aug 1998 A
5807339 Bostrom et al. Sep 1998 A
5830145 Tenhoff Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5868778 Gershony et al. Feb 1999 A
5872879 Hamm Feb 1999 A
5904651 Swanson et al. May 1999 A
5907425 Dickensheets et al. May 1999 A
5935075 Casscells et al. Aug 1999 A
5938602 Lloyd Aug 1999 A
5938671 Katoh et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5951583 Jensen et al. Sep 1999 A
5956355 Swanson et al. Sep 1999 A
5957952 Gershony et al. Sep 1999 A
5987995 Sawatari et al. Nov 1999 A
5997558 Nash Dec 1999 A
6001112 Taylor Dec 1999 A
6007530 Dornhofer et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017359 Gershony et al. Jan 2000 A
6027514 Stine et al. Feb 2000 A
6032673 Savage et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6080170 Nash et al. Jun 2000 A
6106515 Winston et al. Aug 2000 A
6110164 Vidlund Aug 2000 A
6120515 Rogers et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6134002 Stimson et al. Oct 2000 A
6134003 Tearney et al. Oct 2000 A
6152938 Curry Nov 2000 A
6152951 Hashimoto et al. Nov 2000 A
6160826 Swanson et al. Dec 2000 A
6175669 Colston et al. Jan 2001 B1
6176871 Pathak et al. Jan 2001 B1
6183432 Milo Feb 2001 B1
6193676 Winston et al. Feb 2001 B1
6206898 Honeycutt et al. Mar 2001 B1
6228076 Winston et al. May 2001 B1
6241744 Imran et al. Jun 2001 B1
6283957 Hashimoto et al. Sep 2001 B1
6285903 Rosenthal et al. Sep 2001 B1
6290668 Gregory et al. Sep 2001 B1
6294775 Seibel et al. Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6307985 Murakami et al. Oct 2001 B1
6375615 Flaherty et al. Apr 2002 B1
6402719 Ponzi et al. Jun 2002 B1
6416527 Berg et al. Jul 2002 B1
6445939 Swanson et al. Sep 2002 B1
6445944 Ostrovsky Sep 2002 B1
6447525 Follmer et al. Sep 2002 B2
6451036 Heitzmann et al. Sep 2002 B1
6454717 Pantages et al. Sep 2002 B1
6454779 Taylor Sep 2002 B1
6482216 Hiblar et al. Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6485413 Boppart et al. Nov 2002 B1
6497649 Parker et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6503261 Bruneau et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6517528 Pantages et al. Feb 2003 B1
6542665 Reed et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551302 Rosinko et al. Apr 2003 B1
6563105 Seibel et al. May 2003 B2
6564087 Pitris et al. May 2003 B1
6565588 Clement et al. May 2003 B1
6572563 Ouchi et al. Jun 2003 B2
6572643 Gharibadeh Jun 2003 B1
6575995 Huter et al. Jun 2003 B1
6579298 Bruneau et al. Jun 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6629953 Boyd Oct 2003 B1
6638233 Corvi et al. Oct 2003 B2
6645217 MacKinnon et al. Nov 2003 B1
6657727 Izatt et al. Dec 2003 B1
6666874 Heitzmann et al. Dec 2003 B2
6687010 Horii Feb 2004 B1
6728571 Barbato Apr 2004 B1
D489973 Root et al. May 2004 S
6730063 Delaney et al. May 2004 B2
6758854 Butler et al. Jul 2004 B1
6760112 Reed et al. Jul 2004 B2
6800085 Selmon et al. Oct 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6845190 Smithwick et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6853457 Bjarklev et al. Feb 2005 B2
6856712 Fauver et al. Feb 2005 B2
6867753 Chinthammit et al. Mar 2005 B2
6879851 McNamara et al. Apr 2005 B2
6947787 Webler Sep 2005 B2
6961123 Wang et al. Nov 2005 B1
6970732 Winston et al. Nov 2005 B2
6975898 Seibel Dec 2005 B2
7068878 Crossman-Bosworth et al. Jun 2006 B2
7074231 Jang Jul 2006 B2
7126693 Everett et al. Oct 2006 B2
7172610 Heitzmann et al. Feb 2007 B2
7242480 Alphonse Jul 2007 B2
7261687 Yang Aug 2007 B2
7288087 Winston et al. Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297131 Nita Nov 2007 B2
7311723 Seibel et al. Dec 2007 B2
7344546 Wulfman et al. Mar 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7426036 Feldchtein et al. Sep 2008 B2
7428001 Schowengerdt et al. Sep 2008 B2
7428053 Feldchtein et al. Sep 2008 B2
7455649 Root et al. Nov 2008 B2
7474407 Gutin Jan 2009 B2
7485127 Nistal Feb 2009 B2
7488340 Kauphusman et al. Feb 2009 B2
7530948 Seibel et al. May 2009 B2
7530976 MacMahon et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7538886 Feldchtein May 2009 B2
7539362 Teramura May 2009 B2
7542145 Toida et al. Jun 2009 B2
7544162 Ohkubo Jun 2009 B2
7545504 Buckland et al. Jun 2009 B2
7555333 Wang et al. Jun 2009 B2
7577471 Camus et al. Aug 2009 B2
7583872 Seibel et al. Sep 2009 B2
7616986 Seibel et al. Nov 2009 B2
7637885 Maschke Dec 2009 B2
7674253 Fisher et al. Mar 2010 B2
7682319 Martin et al. Mar 2010 B2
7706863 Imanishi et al. Apr 2010 B2
7728985 Feldchtein et al. Jun 2010 B2
7729745 Maschke Jun 2010 B2
7734332 Sher Jun 2010 B2
7738945 Fauver et al. Jun 2010 B2
7753852 Maschke Jul 2010 B2
7771425 Dycus et al. Aug 2010 B2
7785286 Magnin et al. Aug 2010 B2
7813609 Petersen et al. Oct 2010 B2
7821643 Amazeen et al. Oct 2010 B2
7824089 Charles Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7944568 Teramura et al. May 2011 B2
7952718 Li et al. May 2011 B2
7972299 Carter et al. Jul 2011 B2
8059274 Splinter Nov 2011 B2
8062316 Patel et al. Nov 2011 B2
8068921 Prakash et al. Nov 2011 B2
8361097 Patel et al. Jan 2013 B2
8548571 He et al. Oct 2013 B2
8548603 Swoyer et al. Oct 2013 B2
8644913 Simpson et al. Feb 2014 B2
8647335 Markus Feb 2014 B2
8696695 Patel et al. Apr 2014 B2
8911459 Simpson et al. Dec 2014 B2
9125562 Spencer et al. Sep 2015 B2
9333007 Escudero et al. May 2016 B2
9345398 Tachibana et al. May 2016 B2
9345406 Spencer et al. May 2016 B2
9345510 Patel et al. May 2016 B2
9498247 Patel et al. Nov 2016 B2
9498600 Rosenthal et al. Nov 2016 B2
9557156 Kankaria Jan 2017 B2
9572492 Simpson et al. Feb 2017 B2
9592075 Simpson et al. Mar 2017 B2
9642646 Patel et al. May 2017 B2
9788790 Black et al. Oct 2017 B2
9854979 Smith et al. Jan 2018 B2
9918734 Patel et al. Mar 2018 B2
9949754 Newhauser et al. Apr 2018 B2
20010005788 McGuckin, Jr. Jun 2001 A1
20010020126 Swanson et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020072706 Hiblar et al. Jun 2002 A1
20020082585 Carroll et al. Jun 2002 A1
20020082626 Donohoe et al. Jun 2002 A1
20020111548 Swanson et al. Aug 2002 A1
20020115931 Strauss et al. Aug 2002 A1
20020147459 Bashiri et al. Oct 2002 A1
20020158547 Wood Oct 2002 A1
20030002038 Mawatari Jan 2003 A1
20030028100 Tearney et al. Feb 2003 A1
20030032880 Moore Feb 2003 A1
20030045835 Anderson et al. Mar 2003 A1
20030095248 Frot May 2003 A1
20030097044 Rovegno May 2003 A1
20030120150 Govari Jun 2003 A1
20030120295 Simpson et al. Jun 2003 A1
20030125756 Shturman et al. Jul 2003 A1
20030125757 Patel et al. Jul 2003 A1
20030125758 Simpson et al. Jul 2003 A1
20030139751 Evans et al. Jul 2003 A1
20030181855 Simpson et al. Sep 2003 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040039371 Tockman et al. Feb 2004 A1
20040057667 Yamada et al. Mar 2004 A1
20040059257 Gaber Mar 2004 A1
20040082850 Bonner et al. Apr 2004 A1
20040092915 Levatter May 2004 A1
20040093001 Hamada May 2004 A1
20040147934 Kiester Jul 2004 A1
20040167553 Simpson et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040181249 Torrance et al. Sep 2004 A1
20040186368 Ramzipoor et al. Sep 2004 A1
20040202418 Ghiron et al. Oct 2004 A1
20040220519 Wulfman et al. Nov 2004 A1
20040230212 Wulfman Nov 2004 A1
20040230213 Wulfman et al. Nov 2004 A1
20040236312 Nistal et al. Nov 2004 A1
20040243162 Wulfman et al. Dec 2004 A1
20040254599 Lipoma et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050020925 Kleen et al. Jan 2005 A1
20050043614 Huizenga et al. Feb 2005 A1
20050054947 Goldenberg Mar 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050085708 Fauver et al. Apr 2005 A1
20050085721 Fauver et al. Apr 2005 A1
20050105097 Fang-Yen et al. May 2005 A1
20050141843 Warden et al. Jun 2005 A1
20050154407 Simpson Jul 2005 A1
20050159712 Andersen Jul 2005 A1
20050159731 Lee Jul 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177068 Simpson Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050187571 Maschke Aug 2005 A1
20050192496 Maschke Sep 2005 A1
20050201662 Petersen et al. Sep 2005 A1
20050203553 Maschke Sep 2005 A1
20050222519 Simpson Oct 2005 A1
20050222663 Simpson et al. Oct 2005 A1
20050251116 Steinke et al. Nov 2005 A1
20060011820 Chow-Shing et al. Jan 2006 A1
20060032508 Simpson Feb 2006 A1
20060046235 Alexander Mar 2006 A1
20060049587 Cornwell Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060084911 Belef et al. Apr 2006 A1
20060109478 Tearney et al. May 2006 A1
20060135870 Webler Jun 2006 A1
20060173475 Lafontaine et al. Aug 2006 A1
20060229646 Sparks Oct 2006 A1
20060229659 Gifford et al. Oct 2006 A1
20060235262 Arnal et al. Oct 2006 A1
20060235366 Simpson Oct 2006 A1
20060236019 Soito et al. Oct 2006 A1
20060239982 Simpson Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060264741 Prince Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070010840 Rosenthal et al. Jan 2007 A1
20070015969 Feldman et al. Jan 2007 A1
20070015979 Redel Jan 2007 A1
20070035855 Dickensheets Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070038173 Simpson Feb 2007 A1
20070078469 Soito et al. Apr 2007 A1
20070078500 Ryan et al. Apr 2007 A1
20070081166 Brown et al. Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070106155 Goodnow et al. May 2007 A1
20070135712 Maschke Jun 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070196926 Soito et al. Aug 2007 A1
20070219484 Straub Sep 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070255252 Mehta Nov 2007 A1
20070270647 Nahen et al. Nov 2007 A1
20070276419 Rosenthal Nov 2007 A1
20070288036 Seshadri Dec 2007 A1
20070299309 Seibel et al. Dec 2007 A1
20080004643 To et al. Jan 2008 A1
20080004644 To et al. Jan 2008 A1
20080004645 To et al. Jan 2008 A1
20080004646 To et al. Jan 2008 A1
20080015491 Bei et al. Jan 2008 A1
20080027334 Langston Jan 2008 A1
20080033396 Danek et al. Feb 2008 A1
20080045986 To et al. Feb 2008 A1
20080049234 Seitz Feb 2008 A1
20080058629 Seibel et al. Mar 2008 A1
20080065124 Olson Mar 2008 A1
20080065125 Olson Mar 2008 A1
20080065205 Nguyen et al. Mar 2008 A1
20080095421 Sun et al. Apr 2008 A1
20080103439 Torrance et al. May 2008 A1
20080103446 Torrance et al. May 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080132929 O'Sullivan et al. Jun 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080146942 Dala-Krishna Jun 2008 A1
20080147000 Seibel et al. Jun 2008 A1
20080154293 Taylor et al. Jun 2008 A1
20080177138 Courtney et al. Jul 2008 A1
20080186501 Xie Aug 2008 A1
20080221388 Seibel et al. Sep 2008 A1
20080228033 Tumlinson et al. Sep 2008 A1
20080243030 Seibel et al. Oct 2008 A1
20080243031 Seibel et al. Oct 2008 A1
20080262312 Carroll et al. Oct 2008 A1
20080275485 Bonnette et al. Nov 2008 A1
20090018565 To et al. Jan 2009 A1
20090018566 Escudero et al. Jan 2009 A1
20090018567 Escudero et al. Jan 2009 A1
20090024084 Khosla et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090024191 Seibel et al. Jan 2009 A1
20090028407 Seibel et al. Jan 2009 A1
20090028507 Jones et al. Jan 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090073444 Wang Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090099641 Wu et al. Apr 2009 A1
20090125019 Douglass et al. May 2009 A1
20090135280 Johnston et al. May 2009 A1
20090137893 Seibel et al. May 2009 A1
20090152664 Tian et al. Jun 2009 A1
20090185135 Volk Jul 2009 A1
20090196554 Irisawa Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090208143 Yoon et al. Aug 2009 A1
20090216180 Lee et al. Aug 2009 A1
20090221904 Shealy et al. Sep 2009 A1
20090221920 Boppart et al. Sep 2009 A1
20090235396 Wang et al. Sep 2009 A1
20090244485 Walsh et al. Oct 2009 A1
20090244547 Ozawa Oct 2009 A1
20090264826 Thompson Oct 2009 A1
20090292199 Bielewicz et al. Nov 2009 A1
20090318862 Ali et al. Dec 2009 A1
20100021926 Noordin Jan 2010 A1
20100049225 To et al. Feb 2010 A1
20100125253 Olson May 2010 A1
20100217245 Prescott Aug 2010 A1
20100253949 Adler et al. Oct 2010 A1
20100324472 Wulfman Dec 2010 A1
20110118660 Torrance et al. May 2011 A1
20110201924 Tearney et al. Aug 2011 A1
20130096589 Spencer et al. Apr 2013 A1
20130296695 Spencer et al. Nov 2013 A1
20140005534 He et al. Jan 2014 A1
20150141816 Gupta et al. May 2015 A1
20150208922 Simpson et al. Jul 2015 A1
20150320975 Simpson et al. Nov 2015 A1
20160008025 Gupta et al. Jan 2016 A1
20160038030 Smith et al. Feb 2016 A1
20160135832 Simpson et al. May 2016 A1
20160144155 Simpson et al. May 2016 A1
20160262791 Patel et al. Sep 2016 A1
20160262839 Spencer et al. Sep 2016 A1
20160338582 Tachibana et al. Nov 2016 A1
20170065293 Rosenthal et al. Mar 2017 A1
20170065295 Patel et al. Mar 2017 A1
20170238803 Kankaria Aug 2017 A1
20170238808 Simpson et al. Aug 2017 A1
20170273711 Simpson et al. Sep 2017 A1
20180042520 Patel et al. Feb 2018 A1
20180049700 Black et al. Feb 2018 A1
20180146978 Patel et al. May 2018 A1
20190313941 Radjabi Oct 2019 A1
20200060718 Patel et al. Feb 2020 A1
20200069253 Black et al. Mar 2020 A1
20200069327 Patel et al. Mar 2020 A1
Foreign Referenced Citations (65)
Number Date Country
1875242 Dec 2006 CN
1947652 Apr 2007 CN
202006018883.5 Feb 2007 DE
0347098 Dec 1989 EP
0808638 Nov 1997 EP
0845692 Nov 2005 EP
1859732 Nov 2007 EP
2090245 Aug 2009 EP
2353526 Sep 2013 EP
S62-275425 Nov 1987 JP
03502060 Feb 1990 JP
05103763 Apr 1993 JP
06027343 Feb 1994 JP
07308393 Nov 1995 JP
2002214127 Jul 2002 JP
2004509695 Apr 2004 JP
2004516073 Jun 2004 JP
2005114473 Apr 2005 JP
2005230550 Sep 2005 JP
2005249704 Sep 2005 JP
2005533533 Nov 2005 JP
2008175698 Jul 2006 JP
2006288775 Oct 2006 JP
2006313158 Nov 2006 JP
2006526790 Nov 2006 JP
2006326157 Dec 2006 JP
200783053 Apr 2007 JP
200783057 Apr 2007 JP
2007225349 Sep 2007 JP
2007533361 Nov 2007 JP
2008023627 Feb 2008 JP
2008128708 Jun 2008 JP
2008145376 Jun 2008 JP
2008183208 Aug 2008 JP
2008253492 Oct 2008 JP
200914751 Jan 2009 JP
2009509690 Mar 2009 JP
200978150 Apr 2009 JP
2009066252 Apr 2009 JP
2009201969 Sep 2009 JP
2010518900 Jun 2010 JP
20070047221 May 2007 KR
2185859 Jul 2002 RU
2218191 Dec 2003 RU
WO9117698 Nov 1991 WO
WO9923958 May 1999 WO
WO0054659 Sep 2000 WO
WO0115609 Mar 2001 WO
WO0176680 Oct 2001 WO
WO2006133030 Dec 2006 WO
WO2008005888 Jan 2008 WO
WO2008029506 Mar 2008 WO
WO2008042987 Apr 2008 WO
WO2008051951 May 2008 WO
WO2008065600 Jun 2008 WO
WO2008086613 Jul 2008 WO
WO2008087613 Jul 2008 WO
WO2009005779 Jan 2009 WO
WO2009006335 Jan 2009 WO
WO2009009799 Jan 2009 WO
WO2009009802 Jan 2009 WO
WO2009023635 Feb 2009 WO
WO2009024344 Feb 2009 WO
WO2009094341 Jul 2009 WO
WO2019204797 Oct 2019 WO
Non-Patent Literature Citations (25)
Entry
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005.
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987.
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990.
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages.
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994.
Smith et al.; U.S. Appl. No. 15/854,579 entitled “Chronic total occlusion crossing devices with imaging,” filed Dec. 26, 2017.
Patel et al.; U.S. Appl. No. 15/741,928 entitled “Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters,” filed Jan. 4, 2018.
Zung et al.; U.S. Appl. No. 15/741,773 entitled “Self-alignment mechanism for imaging catheter and drive assembly,” filed Jan. 4, 2018.
Simpson et al.; U.S. Appl. No. 16/194,183 entitled “Identification of elastic lamina to guide interventional therapy,” filed Nov. 16, 2018.
Fernandez et al., U.S. Appl. No. 16/305,136 entitled “Catheter device with detachable distal end,” filed Nov. 28, 2018.
Patel et al., U.S. Appl. No. 16/310,470 entitled “Atherectomy catheter with shapeable distal tip,” filed Dec. 17, 2019.
Christensen; U.S. Appl. No. 16/069,545 entitled “OCT imaging catheter with lag correction,” filed Jul. 12, 2018.
Rosenthal et al.; U.S. Appl. No. 16/105,743 entitled “Atherectomy catheter with laterally-displaceable tip,” filed Aug. 20, 2018.
Patel et al.; U.S. Appl. No. 16/148,246 entitled “Atherectomy catheter with serrated cutter,” filed Oct. 1, 2018.
Choma et al.; Sensitivity advantage of swept source and fourier domain optical coherence tomography; Optics Express; 11(18); pp. 2183-2189; Sep. 8, 2003.
De Boer et al.; Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography; Optics Letters; 28(21); pp. 2067-2069; Nov. 2003.
Leitgeb et al.; Performance of fourier domain vs time domain optical coherence tomography; Optics Express; 11(8); pp. 889-894; Apr. 21, 2003.
Rollins et al.; Optimal interferometer designs for optical coherence tomography; Optics Letters; 24(21); pp. 1484-1486; Nov. 1999.
Tachibana et al.; U.S. Appl. No. 16/372,112 entitled “Atherectomy catheter drive assemblies” filed Apr. 1, 2019.
Newhauser et al.; U.S. Appl. No. 15/954,407 entitled “Occlusion-crossing devices,” filed Apr. 16, 2018.
Patel et al.; U.S. Appl. No. 16/681,807 entitled “Atherectomy catheters and occlusion crossing devices,” filed Nov. 12, 2019.
Bayer Material Science: ; Snap-Fit Joints for Plastics; 26 pages; retrieved from the Internet: ( https://web.archive.org/web/20121119232733if_/http://fab.cba.mit.edu:80/classes/S62.12/people/vernelle.noel/Plastic_Snap_fit_design.pdf) on Sep. 26, 2018.
Schmitt et al.; A new rotational thrombectomy catheter; System design and first clinical esperiences; Cardiovascular and Interventional Radiology; Sprinver-Verlag; 22(6); pp: 504-509; Nov. 1, 1999.
Sharma et al.; Common-path optical coherence tomography with side-viewing bare fiber probe for endoscopic optical coherence tomography; vol. 78; 113102; 5 pages; Nov. 6, 2007.
Stamper et al.; Plaque characterization with optical coherence tomography. Journal of the American College of Cardiology. 47(8); pp. 69-79; Apr. 18, 2006.
Related Publications (1)
Number Date Country
20180256187 A1 Sep 2018 US
Continuations (3)
Number Date Country
Parent 13752325 Jan 2013 US
Child 15922058 US
Parent 13277167 Oct 2011 US
Child 13752325 US
Parent 12108433 Apr 2008 US
Child 13277167 US